by John Conrad | Sep 26, 2025 | Policy News
John Conrad, President and CEO of the Illinois Biotechnology Innovation Organization (iBIO) issued the following response regarding proposed 100% import duties on proprietary pharmaceutical products: “iBIO supports expanding domestic life sciences manufacturing....
by John Conrad | Sep 10, 2025 | Grants, iBIO News
G2G Consulting has released the September Government Bioscience Grants (GBG) report for iBIO members through our exclusive partnership, featuring 104 non-dilutive funding opportunities across biotechnology and life sciences. Members can join G2G’s Monthly GBG...
by John Conrad | Aug 21, 2025 | Policy News
iBIO has joined AdvaMed and 65 other organizations in urging the Centers for Medicare and Medicaid Services (CMS) to create a streamlined pathway for Medicare patients to access FDA-authorized breakthrough medical technology. The coalition’s letter to CMS...
by John Conrad | Aug 20, 2025 | iBIO News, Policy News
The Illinois Biotechnology Innovation Organization (iBIO) delivered a coalition lettercoalition letter signed by 74 companies and organizations from across Illinois to the state’s U.S. Congressional delegation, urging immediate action to reauthorize the Small Business...
by John Conrad | Aug 14, 2025 | iBIO News
The latest Government Bioscience Grants (GBG) report from G2G Consulting identifies 78 non-dilutive funding opportunities across critical biotech research areas. Key Opportunities Combat Medicine: DARPA’s MASH program seeks autonomous technologies for finding...
